Life Science Company News

Reset
Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

Better Choice Company Board of Directors Authorize Stock Repurchase Program

Read more ››
By: GlobenewsWire - 12 May 2022

Invectys appoints Timothy Papp as its Chief Financial Officer

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Invectys, Inc. | Invectys SA

GBT Announces Five Data Presentations on Sickle Cell Disease at Upcoming EHA2022 Congress

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Global Blood Therapeutics Inc. | Guerbet SA

Cogent Biosciences Announces Presentation at European Hematology Association (EHA) Annual Congress

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Cogent Biosciences, Inc.

Agios to Present Clinical and Translational Data at the European Hematology Association Annual Congress

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Agios Pharmaceuticals, Inc.

Aptose to Hold KOL Event and Corporate Update Thursday, June 2nd

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Aptose Biosciences Inc. | Aptose Biosciences Inc.

Genmab Announces Multiple Abstracts to be Presented at the European Hematology Association (EHA) Annual Congress

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Genmab A/S

Kronos Bio’s Investigational SYK Inhibitors Entospletinib and Lanraplenib to be Featured in Four Poster Presentations at EHA2022 Congress

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Kronos Bio, Inc.

Novartis data at ASCO and EHA showcase latest oncology research and innovation, including in breast and prostate cancer

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Novartis AG | Novan, Inc.

Affimed to Present Preclinical Data Demonstrating Cytotoxic Activity of its Novel Innate Cell Engager AFM28 at the Annual Meeting of the European Hematology Association (EHA)

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Affimed N.V

CRISPR Therapeutics Announces Oral Presentation of New Clinical Data on Anti-CD70 Allogeneic CAR-T Therapy CTX130™ for Patients with T-cell Lymphoma at the Annual European Hematology Association (EHA) 2022 Hybrid Congress

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  CRISPR Therapeutics AG

Mustang Bio Announces Results from Follicular Lymphoma Cohort of Ongoing Phase 1/2 Clinical Trial of MB-106, CD20-Targeted CAR T Therapy, Selected for Oral Presentation at European Hematology Association 2022 Hybrid Congress

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Mustang Investment Consulting (Shanghai) Co., Ltd. | Mustang Bio

CORRECTION: Evelo Biosciences Announces First Quarter 2022 Financial Results and Business Highlights

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Evelo Biosciences, Inc.

Autolus Therapeutics to Present Four Clinical Data Updates at the European Hematology Association Congress

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Autolus Therapeutics plc.

Preat Corporation & Panthera Dental Work Together to Bring Exceptional Metal Implant Bars to Dental Industry

Read more ››
By: GlobenewsWire - 12 May 2022

Apellis Announces Seven Abstracts in PNH to be Presented at the European Hematology Association Congress

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Apellis Pharmaceuticals, Inc.

Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Zealand Pharma A/S

CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children’s Hospital Medical Center (CCHMC) Using CURE’s Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoietic Stem Cell

Read more ››
By: GlobenewsWire - 12 May 2022

AltruBio Announces Completion of Enrollment in Phase 1 Clinical Study of Neihulizumab (ALTB-168) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)

Read more ››
By: GlobenewsWire - 12 May 2022
Related companies:  Altrubio Inc.

GenScript ProBio Establishes Korean Legal Entity and Further Strengthens Cooperation in South Korea and APAC Region

Read more ››
By: PR Newswire Association LLC. - 12 May 2022
Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Click to get started »